Crossmark

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience

Crossref DOI link: https://doi.org/10.1016/j.medcle.2020.07.009

Published Print: 2020-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jiménez-Brítez, Gustavo http://orcid.org/0000-0001-5206-0767
Ruiz, Pablo

Soler, Xavier
Funding

Funding for this research was provided by:

Becas Carlos Antonio López
License Information

Text and Data Mining valid from 2020-11-01
More Information

This article is maintained by: Elsevier

Article Title: Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2020.07.009

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2020.07.001

Content Type: simple-article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.